Analysis of the Responsiveness of Latanoprost, Travoprost, Bimatoprost, and Tafluprost in the Treatment of OAG/OHT Patients

Table 7

Reduction of IOP from baseline of PGAs in LNRs.

Author	Year	Bimatoprost (n)	Travoprost (n)	Latanoprost (n)
Gandolfi and Cimino [18]	2003	6.7 ± 1.5 (15)	N. A	0.7 ± 1.0 (15)
Kammer et al. [16]	2010	2.1 ± 2.4 (128)	1.4 ± 2.5 (132)	N. A
Blondeau et al. [17]	2019	4.9 ± 4.6 (31)	4.3 ± 5.3 (23)	2.9 ± 4.7 (29)